Streetbeat News

Regulatory

EWA

Australia's employment change for August was 64.9K, significantly higher than the estimated 23.0K. The prior figure was revised to -1.4K.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 4:40 am

BTCUSD

ETHUSD

PYPL

Crypto infrastructure provider Paxos has admitted to overpaying a Bitcoin network fee by $510,000 due to a bug affecting a single transfer. The error was initially speculated to involve PayPal Holdings Inc, but Paxos clarified that PayPal was not responsible. Paxos is in discussions with the miner who received the excess fee to recover the funds. PayPal uses Paxos to manage its crypto custody services.

Portfolio Pulse from Mehab Qureshi

September 14, 2023 | 4:02 am

AAPL

The White House has accused China of implementing a ban on Apple Inc.’s iPhones as a retaliatory measure amid ongoing trade tensions. China's foreign ministry spokeswoman denied the existence of specific laws targeting Apple or foreign phone brands. The uncertainty regarding Apple’s status in China, a crucial production base and market for the company, has left investors on edge.

Portfolio Pulse from Ananya Gairola

September 14, 2023 | 3:19 am

AAWH

CURLF

GTBIF

TSNDF

VRNOF

Maryland's cannabis market has seen a significant increase in sales since transitioning from medical to recreational use, with August sales reaching $91.7 million, up from $42.7 million in June. The top cannabis stores in the state are reportedly making $25-30 million each in sales. Maryland's regulator has issued 101 dispensary licenses and plans to release an additional 75. Publicly traded multi-state operators in the market include Ascend (OTC:AAWH), Curaleaf (OTC:CURLF), Green Thumb (OTC:GTBIF), TerrAscend (OTC:TSNDF), and Verano (OTC:VRNOF).

Portfolio Pulse from Nicolás Jose Rodriguez

September 13, 2023 | 9:52 pm

BK

BNPQY

HSBC

HSBC Holdings is reportedly partnering with crypto custody technology business, Fireblocks, to expand into the digital asset space. This comes amid regulatory uncertainties in the U.S. crypto sector. HSBC has previously shown interest in the crypto space, launching Bitcoin and Ethereum ETFs and allowing licensed crypto firms to create bank accounts. Fireblocks, which provides a non-custodial wallet-as-a-service, has been a provider of crypto custody instruments for the Bank of New York Mellon and BNP Paribas since early 2021.

Portfolio Pulse from Khyathi Dalal

September 13, 2023 | 9:07 pm

VINE

Fresh Vine Wine has received a notice from NYSE American stating that the company is not in compliance with the NYSE American Continued Listing Standards relating to stockholders' equity.

Portfolio Pulse from Charles Gross

September 13, 2023 | 9:06 pm

ALNY

Alnylam Pharmaceuticals has reported a positive outcome from an FDA Advisory Committee meeting regarding Patisiran, a treatment for the cardiomyopathy of ATTR amyloidosis. The CRDAC voted 9:3 in favor of the benefits of Patisiran outweighing its risks. The FDA has set an action date of October 8, 2023, under the Prescription Drug User Fee Act.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 9:05 pm

ALNY

The FDA advisory committee has voted in favor of a new indication for Alnylam's drug, Onpattro. This positive development could potentially expand the drug's market and boost Alnylam's revenues.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 8:36 pm

ZOM

Zomedica has received a formal notice from NYSE American stating that it is not in compliance with the exchange's continued listing standard. The company's failure to meet the standard could potentially lead to its delisting.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 8:34 pm

SCNI

Scinai Immunotherapeutics has reported preclinical results for its innovative plaque psoriasis treatment, NanoAbs. The treatment has shown to downregulate key molecular markers overexpressed in plaque psoriasis and helped the stratum corneum regain a normal appearance in a laboratory 3D skin model. Results from an ex-vivo study in human psoriatic skin are expected in Q4 2023, and in-vivo animal study results are anticipated in early 2024.

Portfolio Pulse from Benzinga Newsdesk

September 13, 2023 | 8:24 pm